D.E. Shaw & Co’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-47,432
| Closed | -$1.55M | – | 5801 |
|
|
2022
Q2 | $1.55M | Sell |
47,432
-65,115
| -58% | -$2.06M | ﹤0.01% | 3289 |
|
|
2022
Q1 | $2.96M | Buy |
112,547
+7,395
| +7% | +$181K | ﹤0.01% | 2915 |
|
|
2021
Q4 | $2.5M | Sell |
105,152
-14,722
| -12% | -$363K | ﹤0.01% | 3147 |
|
|
2021
Q3 | $3.01M | Sell |
119,874
-19,649
| -14% | -$501K | ﹤0.01% | 2628 |
|
|
2021
Q2 | $3.63M | Sell |
139,523
-20,589
| -13% | -$560K | ﹤0.01% | 2330 |
|
|
2021
Q1 | $4.1M | Sell |
160,112
-70,163
| -30% | -$1.8M | ﹤0.01% | 2006 |
|
|
2020
Q4 | $4.61M | Sell |
230,275
-16,667
| -7% | -$326K | ﹤0.01% | 1937 |
|
|
2020
Q3 | $4.23M | Sell |
246,942
-47,010
| -16% | -$889K | ﹤0.01% | 1820 |
|
|
2020
Q2 | $6.41M | Buy |
293,952
+136,275
| +86% | +$3.12M | 0.01% | 1477 |
|
|
2020
Q1 | $3.65M | Buy |
157,677
+110,725
| +236% | +$3.22M | 0.01% | 1711 |
|
|
2019
Q4 | $1.55M | Buy |
46,952
+24,395
| +108% | +$782K | ﹤0.01% | 2675 |
|
|
2019
Q3 | $718K | Sell |
22,557
-125,528
| -85% | -$3.66M | ﹤0.01% | 3026 |
|
|
2019
Q2 | $3.8M | Buy |
148,085
+75,938
| +105% | +$1.94M | ﹤0.01% | 1794 |
|
|
2019
Q1 | $1.83M | Buy |
+72,147
| New | +$2.15M | ﹤0.01% | 2208 |
|
|
2018
Q4 | – | Sell |
-54,228
| Closed | -$1.93M | – | 4086 |
|
|
2018
Q3 | $1.93M | Sell |
54,228
-5,818
| -10% | -$205K | ﹤0.01% | 2221 |
|
|
2018
Q2 | $2.07M | Buy |
60,046
+10,455
| +21% | +$366K | ﹤0.01% | 2209 |
|
|
2018
Q1 | $1.67M | Buy |
49,591
+21,288
| +75% | +$674K | ﹤0.01% | 2168 |
|
|
2017
Q4 | $1.08M | Buy |
28,303
+19,065
| +206% | +$761K | ﹤0.01% | 2533 |
|
|
2017
Q3 | $346K | Buy |
+9,238
| New | +$326K | ﹤0.01% | 3085 |
|
|
2016
Q2 | – | Sell |
-61,684
| Closed | -$2.37M | – | 3601 |
|
|
2016
Q1 | $2.37M | Buy |
61,684
+43,477
| +239% | +$1.62M | ﹤0.01% | 1766 |
|
|
2015
Q4 | $875K | Sell |
18,207
-2,081
| -10% | -$96.3K | ﹤0.01% | 2737 |
|
|
2015
Q3 | $800K | Sell |
20,288
-16,749
| -45% | -$712K | ﹤0.01% | 2750 |
|
|
2015
Q2 | $1.58M | Sell |
37,037
-6,350
| -15% | -$253K | ﹤0.01% | 2383 |
|
|
2015
Q1 | $1.71M | Sell |
43,387
-32,576
| -43% | -$1.2M | ﹤0.01% | 2143 |
|
|
2014
Q4 | $2.74M | Buy |
75,963
+7,473
| +11% | +$251K | ﹤0.01% | 2014 |
|
|
2014
Q3 | $2.02M | Buy |
68,490
+22,496
| +49% | +$621K | ﹤0.01% | 2236 |
|
|
2014
Q2 | $1.16M | Sell |
45,994
-13,660
| -23% | -$338K | ﹤0.01% | 2805 |
|
|
2014
Q1 | $1.54M | Sell |
59,654
-16,597
| -22% | -$418K | ﹤0.01% | 2637 |
|
|
2013
Q4 | $1.72M | Buy |
76,251
+61,464
| +416% | +$1.19M | ﹤0.01% | 2665 |
|
|
2013
Q3 | $210K | Buy |
+14,787
| New | +$198K | ﹤0.01% | 4066 |
|
Other funds holding NTUS
D.E. Shaw & Co's NTUS Position: Q3 2022 in Review
D.E. Shaw & Co sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 47,432 shares — an estimated $1.55M sold.
D.E. Shaw & Co first reported a position in NTUS in Q3 2013 and held it in 30 quarters. The position peaked at $6.41M in Q2 2020. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- D.E. Shaw & Co reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 47,432 Natus Medical Inc shares in Q3 2022, an estimated $1.55M.
- D.E. Shaw & Co first reported a position in Natus Medical Inc in Q3 2013 and held it in 30 quarters.
- D.E. Shaw & Co's Natus Medical Inc position peaked at $6.41M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.